Aminopeptidase A, Generating One of the Main Effector Peptides of the Brain Renin-Angiotensin System, Angiotensin III, Plays a Key Role in Central Control of Blood Pressure

Proceedings of the Western Pharmacology Society

Volumn 46, Issue , 2003, Pages 39-44

  Rozenfeld, Raphael ^a   Reaux, Annabelle ^a   Iturrioz, Xavier ^a   Fassot, Celine ^a   Fournie Zaluski, Marie Claude ^a   David, Christelle ^a   Maigret, Bernard ^b   Roques, Bernard Pierre ^a   Corvol, Pierre ^a   Llorens Cortes, Catherine ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN III; DITHIOL DERIVATIVE; ENZYME INHIBITOR; GLUTAMYL AMINOPEPTIDASE; LEUKOTRIENE A4 HYDROLASE; MICROSOMAL AMINOPEPTIDASE; PROTEIN INHIBITOR; SULFONIC ACID DERIVATIVE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; BRAIN METABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; HYPOTHALAMUS; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; X RAY ANALYSIS;

ANGIOTENSIN II; ANGIOTENSIN III; ANIMALS; ANTIGENS, CD13; BINDING SITES; BLOOD PRESSURE; BRAIN CHEMISTRY; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; ENZYME INHIBITORS; GLUTAMYL AMINOPEPTIDASE; HUMANS; MALE; METHIONINE; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENIN-ANGIOTENSIN SYSTEM; SULFHYDRYL COMPOUNDS; SULFONIC ACIDS;

EID: 10744228161     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Saavedra JM: Endocrine Reviews 13:329 (1992).
2. Ganong WF: Frontiers in Neuroendocrinol. 14:233 (1993).
3. Wright JW and Harding JW: Brain Res Brain Res Rev 17:227 (1992).
4. Llorens-Cortes C and Mendelsohn FA: J Renin Angiotensin Aldosterone Syst 3:S39 (2002).
5. Kugler P: Histochemistry 74:247 (1982).
6. Bausback HH, Churchill L, and Ward PE: Biochem. Pharmacol. 37:155 (1988).
7. Wilk S and Healy DP: Advances in Neuroimmunology Vol. 3: pp.195 (1993).
8. Palmieri FE, Bausback HH, and Ward PE: Biochem. Pharmacol. 38:173 (1989).
9. Rozenfeld R, Iturrioz X, Maigret B, and Llorens-Cortes C: J Biol Chem 277:29242 (2002).
10. Thunnissen MM, Nordlund P, and Haeggstrom JZ: Nat Struct Biol 8:131 (2001).
11. Zini S, Fournié-Zaluski MC, Chauvel E, Roques BP, Corvol P, and Llorens-Cortès C: Proc Natl Acad Sci USA 93:11968 (1996).
12. Reaux A, de Mota N, Zini S, Cadel S, Fournie-Zaluski M, Roques BP, Corvol P, and Llorens-Cortes C: Neuroendocrinology 69:370 (1999).
13. Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, and Llorens-Cortes C: Proc Natl Acad Sci U S A 96:13415 (1999).
14. Gaudet E, Blanc J, and Elghozi JL: Am J Physiol 270:R1265 (1996).
15. Danielsen EM, Norén O, Sjöström H, Ingram J, and Kenny AJ: Biochem. J. 189:591 (1980).
16. Lodja Z and Gossrau R: Histochemistry 67:267 (1980).
17. Healy DP and Wilk S: Brain Res. 606:295 (1993).
18. Lenkei Z, Palkovits M, Corvol P, and Llorens-Cortes C: Front Neuroendocrinol 18:383 (1997).
19. Lind R, Swanson L, and Ganten D: Neuroendocrinology 40:2 (1985).
20. Zini S, Masdehors P, Lenkei Z, Fournié-Zaluski MC, Roques BP, Corvol P, and LLorens-Cortès C: Neuroscience 78:1178 (1997).
21. Hooper NM: FEBS Lett. 354:1 (1994).
22. Barett AJ: Methods in Enzymology 244:1 (1994).
23. Wang JY and Cooper MD: Proc. Natl. Acad. Sci. USA 90:1222 (1993).
24. Vazeux G, Wang J, Corvol P, and Llorens-Cortès C: J. Biol. Chem. 271:9069 (1996).
25. Vazeux G, Iturrioz X, Corvol P, and Llorens-Cortes C: Biochem. J. 327: 883 (1997).
26. Beaumont A, O'Donohue MJ, Paredes N, Rousselet N, Assicot M, Bohuon C, Fournié-Zaluski MC, and Roques BP: J. Biol. Chem. 270:16803 (1995).
27. Dion N, LeMoual H, Crine P, and Boileau G: FEBS Lett. 318:301 (1993).
28. Vazeux G, Iturrioz X, Corvol P, and Llorens-Cortes C: Biochem J 334:407 (1998).
29. Luciani N, Marie-Claire C, Ruffet E, Beaumont A, Roques BP, and Fournie-Zaluski MC: Biochemistry 37:686 (1998).
30. Wilk S and Thurston LS: Neuropeptides 16:163 (1990).
31. Roques BP, Noble F, Daugé V, Fournié-Zaluski MC, and Beaumont A: Pharmacol. Rev. 45:87 (1993).
32. Fournié-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Maldonado R, and Roques BP: J. Med. Chem. 35:1259 (1992).
33. Chauvel EN, Coric P, Llorens-Cortès C, Wilk S, Roques BP, and Fournié-Zaluski MC: J. Med. Chem. 37:1339 (1994a).
34. Zini S, Demassey Y, Fournié-Zaluski M-C, Bischoff L, Corvol P, Llorens-Cortes C, and Sanderson P: Neuroreport 9/5:120 (1998).
35. Ganten D, Herman K, Bayer C, Unger T, and Lang RE: Science 221:869 (1983).
36. Phillips MI: Annu. Rev. Physiol. 49:413 (1987).
37. Berecek KH, Webb RL, and Brody MJ: Am J Physiol 244:H852 (1983).
38. Wright JW, Morseth SL, Abhold RH, and Harding JW: Am. J. Physiol. 249:R514 (1985).
39. Wright JW, Tamura-Myers E, Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, and Harding JW: Am J Physiol Regul Integr Comp Physiol 14:14 (2002).